Compounds > 4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine
Page last updated: 2024-09-03

4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine and bcx 1812

4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine has been researched along with bcx 1812 in 1 studies

Compound Research Comparison

Studies
(4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine)		Trials
(4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine)		Recent Studies (post-2010)
(4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine)		Studies
(bcx 1812)		Trials
(bcx 1812)		Recent Studies (post-2010) (bcx 1812)
60025112

Protein Interaction Comparison

ProteinTaxonomy4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine (IC50)bcx 1812 (IC50)
Neuraminidase Influenza A virus (A/Turkey/651242/2006(H5N1))0.0094
Neuraminidase Influenza A virus (A/Wilson-Smith/1933(H1N1))0.946
Neuraminidase Influenza A virus (A/Brisbane/59/2007(H1N1))0.2298
NeuraminidaseInfluenza A virus (A/Puerto Rico/8/1934(H1N1))0.0012
NeuraminidaseInfluenza A virus (A/Wilson-Smith/1933(H1N1))0.0004
NeuraminidaseInfluenza A virus (A/Memphis/1/1971(H3N2))0.002
NeuraminidaseInfluenza B virus (B/Lee/1940)0.008
NeuraminidaseInfluenza A virus (A/Singapore/1/1957(H2N2))0.003
NeuraminidaseInfluenza A virus (A/Brevig Mission/1/1918(H1N1))0.0034

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E1

Other Studies

1 other study(ies) available for 4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine and bcx 1812

ArticleYear
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Bioorganic & medicinal chemistry, 2009, Jan-15, Volume: 17, Issue:2

    Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship

2009